Work

Cloretazine is an effective induction therapy in elderly patients (pts) with poor-risk de novo AML

Year: 2006

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2006.24.18_suppl.6512

Authors: J. E. Karp, D. Rizzieri, N. Vey, G. Mufti, R. Geller, S. O’Brien, F. Giles

Institutions: Johns Hopkins University, Duke University, King's College London, Institut Paoli-Calmettes, Vion Pharmaceuticals (United States)

Language: English

Topic: Acute Myeloid Leukemia Research

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2254740862

Cites:

Cited by: 5

Related to: 10